Applications of samarium complexes as cytotoxic, bioimaging and DNA interacting agents: a comprehensive review
Author:
Inamdar Poonam R.1ORCID, Bhandari Shashikant2, Kulkarni Mrunalini3, Rai Neeta3, Kolsure Anuja4
Affiliation:
1. Department of Pharmaceutical Sciences, School of Health Sciences and Technology , Dr. Vishwanath Karad MIT World Peace University , Pune , India 2. Department of Pharmaceutical Chemistry , AISSMS College of Pharmacy , Kennedy Road , Pune , India 3. Department of Pharmacy , Vishwakarma University , Kondhwa , Pune , India 4. Department of Pharmaceutical Chemistry , JSPM Pharmacy College , Hadapsar , Pune , India
Abstract
Abstract
Cisplatin coined a term Metallodrug and later a tradition of Metallodrugs was established. Later, severe renal and metabolic toxicities of the platinum based drugs prompted the medicinal chemists to develop new and novel metallotherapeutics with different metal cores. Henceforth, chemists designed the metal complexes based on copper, cobalt, vanadium iron and zinc. These complexes were reported for their antibacterial, anticancer, antidiabetic and enzyme inhibitors. Later, chemists also focused on lanthanide metal ions and resulted in the design of metal complexes for the application of bio imaging cellular studies as well as chemotherapeutic agents. This review throws a light on the recent advances in the development of the samarium complexes as efficient and versatile biological agents. Samarium complexes based on various ligand systems and ancillary ligands have been mentioned in this review stating their biological efficacy and potency against variable cancer cell lines, their DNA interactive behaviour.
Publisher
Walter de Gruyter GmbH
Reference22 articles.
1. Kostova, I. Curr. Med. Chem. Anti Cancer Agents 2005, 5, 591–602. 2. Fricker, S. P. Chem. Soc. Rev. 2006, 35, 524–533. 3. Wang, B. D., Yang, Z.-Y., Crewdson, P., Wang, D.-Q. J. Inorg. Biochem. 2007, 101, 1492–1504. 4. Latras, V. M., Coderch, L. C., Villar, F. A., Vina, J. C., Martin, J. M., Carderon, F. M., Bejarano, J. N. M., Cusi, A. S., Bermudez, G. S., Icaza, A. E. Clin. Transl. Oncol. 2005, 5, 198–204. 5. Kostova, I., Momekov, G., Stancheva, P. Met. Base. Drugs 2007, 2007, 1–8.
|
|